Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

High-circulating leptin levels are associated with increased blood pressure in uncontrolled resistant hypertension

Abstract

Leptin and aldosterone have been associated with the pathophysiological mechanisms of hypertension. However, despite studies showing the association of leptin with intima-media thickness, arterial distensibility and sympathetic nerve activation, the relationship between leptin and blood pressure (BP) in resistant hypertension (RHTN) is unknown. We aimed to assess the correlation of plasma leptin and aldosterone levels with BP in uncontrolled controlled RHTN (UCRHTN) and CRHTN patients. Plasma leptin and aldosterone levels, office BP, ambulatory BP monitoring and heart rate were measured in 41 UCRHTN, 39 CRHTN and 31 well-controlled HTN patients. No differences were observed between the three groups regarding gender, body mass index and age. The UCRHTN group had increased leptin when compared with CRHTN and well-controlled HTN patients (38.2±21.4, 19.6±8.7 and 20.94±13.9 ng ml−1, respectively; P<0.05). Aldosterone levels values were also statistically different when comparing RHTN, CRHTN and well-controlled HTN patients (9.6±3.8, 8.1±5.0 and 8.0±4.7 ng dl−1, respectively; P<0.05). As expected, UCRHTN patients had higher heart rate values compared with CRHTN and well-controlled HTN patients (86.2±7.2, 83.5±6.7 and 83.4±8.5, respectively; P<0.05). Plasma leptin positively correlated with systolic (SBP) and diastolic BP (DBP), and aldosterone (r=0.43, 0.35 and 0.47, respectively; all P<0.05) in UCRHTN, but neither in the CRHTN nor in the HTN group. Simple linear regression showed that SBP, DBP and aldosterone may be predicted by leptin (r2=0.16, 0.15 and 0.19, respectively; all P<0.05) only in the UCRHTN subgroup. In conclusion, UCRHTN patients have higher circulating leptin levels associated with increased plasma aldosterone and BP levels when compared with CRHTN and HTN subjects.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Krousel-Wood M, Hyre A, Muntner P, Morisky D . Methods to improve medication adherence in patients with hypertension: current status and future directions. Curr Opin Cardiol 2005; 20 (4): 296–300.

    Article  Google Scholar 

  2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289 (19): 2560–2572.

    Article  CAS  Google Scholar 

  3. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 2008; 51 (6): 1403–1419.

    Article  CAS  Google Scholar 

  4. Muxfeldt ES, Bloch KV, Nogueira AR, Salles GF . Twenty-four hour ambulatory blood pressure monitoring pattern of resistant hypertension. Blood Press Monit 2003; 8 (5): 181–185.

    Article  Google Scholar 

  5. Gelber RP, Gaziano JM, Manson JE, Buring JE, Sesso HD . A prospective study of body mass index and the risk of developing hypertension in men. Am J Hypertens 2007; 20 (4): 370–377.

    Article  Google Scholar 

  6. Kotchen TA, Grim CE, Kotchen JM, Krishnaswami S, Yang H, Hoffmann RG et al. Altered relationship of blood pressure to adiposity in hypertension. Am J Hypertens 2008; 21 (3): 284–289.

    Article  Google Scholar 

  7. Sowers JR, Whaley-Connell A, Epstein M . Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension. Ann Intern Med 2009; 150 (11): 776–783.

    Article  Google Scholar 

  8. Fonseca-Alaniz MH, Takada J, Alonso-Vale MI, Lima FB . Adipose tissue as an endocrine organ: from theory to practice. J Pediatr 2007; 83 (5 Suppl): S192–S203.

    Article  Google Scholar 

  9. Matsumura K, Tsuchihashi T, Fujii K, Iida M . Neural regulation of blood pressure by leptin and the related peptides. Regul Pept 2003; 114 (2–3): 79–86.

    Article  CAS  Google Scholar 

  10. da Silva AA, do Carmo J, Dubinion J, Hall JE . The role of the sympathetic qnervous system in obesity-related hypertension. Curr Hypertens Rep 2009; 11 (3): 206–211.

    Article  CAS  Google Scholar 

  11. Wannamethee SG, Tchernova J, Whincup P, Lowe GD, Kelly A, Rumley A et al. Plasma leptin: associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease. Atherosclerosis 2007; 191 (2): 418–426.

    Article  CAS  Google Scholar 

  12. Singhal A, Farooqi IS, Cole TJ, O'Rahilly S, Fewtrell M, Kattenhorn M et al. Influence of leptin on arterial distensibility: a novel link between obesity and cardiovascular disease? Circulation 2002; 106 (15): 1919–1924.

    Article  CAS  Google Scholar 

  13. Ciccone M, Vettor R, Pannacciulli N, Minenna A, Bellacicco M, Rizzon P et al. Plasma leptin is independently associated with the intima-media thickness of the common carotid artery. Int J Obes Relat Metab Disord 2001; 25 (6): 805–810.

    Article  CAS  Google Scholar 

  14. Martins LC, Figueiredo VN, Quinaglia T, Boer-Martins L, Yugar-Toledo JC, Martin JF et al. Characteristics of resistant hypertension: ageing, body mass index, hyperaldosteronism, cardiac hypertrophy and vascular stiffness. J Hum Hypertens 2011; 25 (9): 532–538.

    Article  CAS  Google Scholar 

  15. de Souza WA, Yugar-Toledo JC, Bergsten-Mendes G, Sabha M, Moreno H . Effect of pharmaceutical care on blood pressure control and health-related quality of life in patients with resistant hypertension. Am J Health Syst Pharm 2007; 64 (18): 1955–1961.

    Article  Google Scholar 

  16. Groppelli A, Omboni S, Parati G, Mancia G . Evaluation of noninvasive blood pressure monitoring devices Spacelabs 90202 and 90207 versus resting and ambulatory 24-hour intra-arterial blood pressure. Hypertension 1992; 20 (2): 227–232.

    Article  CAS  Google Scholar 

  17. Quehenberger P, Exner M, Sunder-Plassmann R, Ruzicka K, Bieglmayer C, Endler G et al. Leptin induces endothelin-1 in endothelial cells in vitro. Circ Res 2002; 90 (6): 711–718.

    Article  CAS  Google Scholar 

  18. Oda A, Taniguchi T, Yokoyama M . Leptin stimulates rat aortic smooth muscle cell proliferation and migration. Kobe J Med Sci 2001; 47 (3): 141–150.

    CAS  PubMed  Google Scholar 

  19. Bouloumie A, Marumo T, Lafontan M, Busse R . Leptin induces oxidative stress in human endothelial cells. FASEB J 1999; 13 (10): 1231–1238.

    Article  CAS  Google Scholar 

  20. Shankar A, Xiao J . Positive relationship between plasma leptin level and hypertension. Hypertension 2010; 56 (4): 623–628.

    Article  CAS  Google Scholar 

  21. Douma S, Petidis K, Doumas M, Papaefthimiou P, Triantafyllou A, Kartali N et al. Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet 2008; 371 (9628): 1921–1926.

    Article  CAS  Google Scholar 

  22. Hilzendeger AM, Morais RL, Todiras M, Plehm R, da Costa Goncalves A, Qadri F et al. Leptin regulates ACE activity in mice. J Mol Med 2010; 88 (9): 899–907.

    Article  CAS  Google Scholar 

  23. Ehrhart-Bornstein M, Arakelyan K, Krug AW, Scherbaum WA, Bornstein SR . Fat cells may be the obesity-hypertension link: human adipogenic factors stimulate aldosterone secretion from adrenocortical cells. Endocr Res 2004; 30 (4): 865–870.

    Article  CAS  Google Scholar 

  24. Turnbull AV, Rivier CL . Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol Rev 1999; 79 (1): 1–71.

    Article  CAS  Google Scholar 

  25. Elmquist JK, Ahima RS, Maratos-Flier E, Flier JS, Saper CB . Leptin activates neurons in ventrobasal hypothalamus and brainstem. Endocrinology 1997; 138 (2): 839–842.

    Article  CAS  Google Scholar 

  26. Williams GH . Aldosterone biosynthesis, regulation, and classical mechanism of action. Heart Fail Rev 2005; 10 (1): 7–13.

    Article  CAS  Google Scholar 

  27. Stas S, Whaley-Connell A, Habibi J, Appesh L, Hayden MR, Karuparthi PR et al. Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling. Endocrinology 2007; 148 (8): 3773–3780.

    Article  CAS  Google Scholar 

  28. Kalil GZ, Haynes WG . Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications. Hypertens Res 2012; 35 (1)): 4–16.

    Article  CAS  Google Scholar 

  29. Ziccardi P, Nappo F, Giugliano G, Esposito K, Marfella R, Cioffi M et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002; 105 (7): 804–809.

    Article  CAS  Google Scholar 

  30. Pimenta E, Gaddam KK, Oparil S, Aban I, Husain S, Dell'Italia LJ et al. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertension 2009; 54 (3): 475–481.

    Article  CAS  Google Scholar 

  31. Chapman N, Dobson J, Wilson S, Dahlof B, Sever PS, Wedel H et al. Effect of spironolactone on blood pressure in subjects with resistant hypertension. Hypertension 2007; 49 (4): 839–845.

    Article  CAS  Google Scholar 

  32. Guo C, Ricchiuti V, Lian BQ, Yao TM, Coutinho P, Romero JR et al. Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines. Circulation 2008; 117 (17): 2253–2261.

    Article  CAS  Google Scholar 

  33. Furumatsu Y, Nagasawa Y, Tomida K, Mikami S, Kaneko T, Okada N et al. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker. Hypertens Res 2008; 31 (1): 59–67.

    Article  CAS  Google Scholar 

  34. Rahmouni K, Haynes WG, Morgan DA, Mark AL . Selective resistance to central neural administration of leptin in agouti obese mice. Hypertension 2002; 39 (2, Part 2): 486–490.

    Article  CAS  Google Scholar 

  35. Gomez R, Lago F, Gomez-Reino JJ, Gualillo O . Novel factors as therapeutic targets to treat diabetes. Focus on leptin and ghrelin. Expert Opin Ther Targets 2009; 13 (5): 583–591.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by the State of São Paulo Research Foundation (FAPESP) Brazil, National Council for Scientific and Technological Development (CNPq) and Coordination for the Improvement of Higher Education Personnel (Capes), Brazil.

Caroline Demacq is an employee of Novartis Biociências SA (Brazil).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C de Haro Moraes.

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Haro Moraes, C., Figueiredo, V., de Faria, A. et al. High-circulating leptin levels are associated with increased blood pressure in uncontrolled resistant hypertension. J Hum Hypertens 27, 225–230 (2013). https://doi.org/10.1038/jhh.2012.29

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2012.29

Keywords

This article is cited by

Search

Quick links